These results suggest a novel regulatory axis of miR‐27a‐3p and Sfrp1 in modulating the osteogenic differentiation of BMSCs, which provides critical insights into the clinical diagnosis and treatment of osteoporosis. The gene discussed is SFRP1; the disease is osteoporosis.